KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Amortization of Deferred Charges (2016 - 2018)

Halozyme Therapeutics (HALO) has disclosed Amortization of Deferred Charges for 7 consecutive years, with -$455000.0 as the latest value for Q4 2018.

  • Quarterly Amortization of Deferred Charges rose 26.26% to -$455000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2018, down 12.27% year-over-year, with the annual reading at $1.5 million for FY2018, 12.27% down from the prior year.
  • Amortization of Deferred Charges for Q4 2018 was -$455000.0 at Halozyme Therapeutics, down from $303000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $3.7 million in Q3 2016, with the low at -$6.3 million in Q4 2016.
  • Average Amortization of Deferred Charges over 5 years is $505888.9, with a median of $447000.0 recorded in 2014.
  • Peak annual rise in Amortization of Deferred Charges hit 315.14% in 2016, while the deepest fall reached 104166.67% in 2016.
  • Over 5 years, Amortization of Deferred Charges stood at $415000.0 in 2014, then plummeted by 101.45% to -$6000.0 in 2015, then plummeted by 104166.67% to -$6.3 million in 2016, then surged by 90.14% to -$617000.0 in 2017, then rose by 26.26% to -$455000.0 in 2018.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at -$455000.0, $303000.0, and $345000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.